News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nouveau Life Pharmaceuticals (NOUV) Announces Release of Its Female Supplement


5/31/2012 11:09:50 AM

FORT LAUDERDALE, Fla., May 30, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals, Inc. (Pink Sheets: NOUV) announced today the release of the first product in the Company's New Life Naturals line of quality, all-natural dietary supplements.

The new supplement New Life Naturals: For Her Senses is an all-natural product intended to help the nearly 48% of American women suffering with female sexual dysfunction (FSD). Each capsule of For Her Senses contains a special blend of herbs best known for their aphrodisiac qualities, including Horny Goat Weed, Macuna Pruriens, Tongkat Ali, Polypodium Vulgare, Saw Palmetto, Muira Puama, Arginine, Maca, and Panax Ginseng. The supplement is being sold in 60-count bottles.

Nouveau Life Pharmaceuticals began work on the For Her Senses formulation in February of this year and began production in April at an FDA-approved manufacturing facility based in the U.S. The Company plans to distribute New Life Naturals: For Her Senses through multiple online sales channels, independent retailers, and health professionals.

About Nouveau Life Pharmaceuticals

The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.

CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993

SOURCE Nouveau Life Pharmaceuticals, Inc.


Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES